Masafumi Ueno

2.2k total citations
69 papers, 1.5k citations indexed

About

Masafumi Ueno is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Masafumi Ueno has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 27 papers in Surgery and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Masafumi Ueno's work include Antiplatelet Therapy and Cardiovascular Diseases (34 papers), Coronary Interventions and Diagnostics (17 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Masafumi Ueno is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (34 papers), Coronary Interventions and Diagnostics (17 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Masafumi Ueno collaborates with scholars based in Japan, United States and Spain. Masafumi Ueno's co-authors include Dominick J. Angiolillo, José Luis Ferreiro, Antonio Tello‐Montoliu, Shinya Goto, Theodore A. Bass, Davide Capodanno, Bhaloo Desai, Andrew Darlington, Salvatore D. Tomasello and Murali Kodali and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Masafumi Ueno

61 papers receiving 1.5k citations

Peers

Countries citing papers authored by Masafumi Ueno

Since Specialization

Citations

This map shows the geographic impact of Masafumi Ueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Ueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Ueno more than expected).

Fields of papers citing papers by Masafumi Ueno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Ueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Ueno. The network helps show where Masafumi Ueno may publish in the future.

Co-authorship network of co-authors of Masafumi Ueno

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Ueno. A scholar is included among the top collaborators of Masafumi Ueno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Ueno. Masafumi Ueno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incremental value of physiological indices to predict high-risk plaques detected by NIRS-IVUS 2025 ·Cardiovascular Intervention and Therapeutics ·(unknown), Masafumi Ueno, Nobuhiro Yamada, (unknown), (unknown), (unknown), (unknown), Kosuke Fujita, (unknown), Koichiro Matsumura, Gaku Nakazawa	0
2	Relationship between hearing thresholds and cognitive function in hearing aid non-users and long-term users post-midlife 2025 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Yasunori Sato, Makoto Hosoya, (unknown), (unknown), Masafumi Ueno, Hiroyuki Ozawa, Naoki Oishi	1
3	Impact of low-density lipoprotein cholesterol-lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome 2025 ·BMC Cardiovascular Disorders ·(unknown), Masafumi Ueno, (unknown), Nobuhiro Yamada, (unknown), (unknown), (unknown), (unknown), Kosuke Fujita, (unknown), Koichiro Matsumura, Gaku Nakazawa	0
4	Sarcopenia accompanied by systemic inflammation can predict clinical outcomes in patients with head and neck cancer undergoing curative therapy 2024 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Masafumi Ueno, (unknown), (unknown), Seiichi Shinden, Hiroyuki Ozawa	3
5	Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella: a retrospective cohort study 2024 ·Journal of Intensive Care ·Nobuhiro Yamada, Masafumi Ueno, (unknown), (unknown), (unknown), Kosuke Fujita, Koichiro Matsumura, Gaku Nakazawa	1
6	Impact of an mHealth App (Kencom) on Patients With Untreated Hypertension Initiating Antihypertensive Medications: Real-World Cohort Study 2024 ·JMIR Cardio ·Koichiro Matsumura, Atsushi Nakagomi, (unknown), Nobuhiro Yamada, (unknown), (unknown), (unknown), (unknown), Masafumi Ueno, Gaku Nakazawa, Takahiro Tabuchi	0
7	Impact of quantitative flow ratio on graft function in patients undergoing coronary artery bypass grafting 2023 ·Cardiovascular Intervention and Therapeutics ·(unknown), Kuniaki Takahashi, (unknown), Masafumi Ueno, Tsutomu Fujita, (unknown), Tetsuya Tobaru, Shuichiro Takanashi, Yoshihisa Kinoshita, Yasuhide Okawa, Yasushi Fuku, Tatsuhiko Komiya, Kenichi Tsujita, Toshihiro Fukui, Tomoki Shimokawa, Yusuke Watanabe, Ken Kozuma, Genichi Sakaguchi, Gaku Nakazawa	3
8	Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction 2023 ·Journal of Cardiovascular Pharmacology and Therapeutics ·Koichiro Matsumura, Takeshi Ijichi, Junko Morimoto, Kensuke Takabayashi, (unknown), Keisuke Ueno, (unknown), Toru Takase, Masafumi Ueno, Gaku Nakazawa	2
9	Haemodynamic effects of inhaled nitric oxide in acute myocardial infarction complicated by right heart failure under ECPELLA support: case report 2023 ·European Heart Journal - Case Reports ·(unknown), Masafumi Ueno, Masakazu Yasuda, Kazuki Mizutani, Tatsuya Miyoshi, Gaku Nakazawa	4
10	Cancer screening: Possibility of underscreening in older adult population with a history of cardiovascular disease 2022 ·Journal of Cardiology ·Koichiro Matsumura, (unknown), Takahiro Tabuchi, Toru Takase, Masahiro Maruyama, Masafumi Ueno, Gaku Nakazawa	1
11	Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion 2021 ·BMC Cardiovascular Disorders ·Takashi Nakamura, (unknown), Masakazu Yasuda, (unknown), Masafumi Ueno, Kenji Yamaji, Kazuki Mizutani, Takashi Kurita, Gaku Nakazawa	2
12	Retrograde-angioscopy guided wiring technique in chronic total occlusion lead to successful revascularization 2020 ·Journal of Cardiology Cases ·Kenji Yamaji, Kazuhiro Kobuke, (unknown), Masakazu Yasuda, Masafumi Ueno, Takashi Kurita, Yoshitaka Iwanaga	2
13	Delayed onset of neointimal dissection within a drug-eluting stent deployed in the left main coronary artery 2019 ·Coronary Artery Disease ·Takashi Nakamura, Masakazu Yasuda, Masafumi Ueno, Kazuhiro Kobuke, Yoshitaka Iwanaga, Shunichi Miyazaki	0
14	Impact of Prasugrel Reload Dosing Regimens on High On-Treatment Platelet Reactivity Rates in Patients on Maintenance Prasugrel Therapy 2013 ·JACC: Cardiovascular Interventions ·José Luis Ferreiro, Masafumi Ueno, Antonio Tello‐Montoliu, Salvatore D. Tomasello, Naveen Seecheran, Bhaloo Desai, Fabiana Rollini, Luis A. Guzmán, Theodore A. Bass, Dominick J. Angiolillo	9
15	Cigarette Smoking Is Associated With a Dose-Response Effect in Clopidogrel-Treated Patients With Diabetes Mellitus and Coronary Artery Disease 2012 ·JACC: Cardiovascular Interventions ·Masafumi Ueno, José Luis Ferreiro, Bhaloo Desai, Salvatore D. Tomasello, Antonio Tello‐Montoliu, Davide Capodanno, Piera Capranzano, Murali Kodali, Kodlipet Dharmashankar, Ronald K. Charlton, Theodore A. Bass, Dominick J. Angiolillo	40
16	Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease 2011 ·Journal of the American College of Cardiology ·Dominick J. Angiolillo, Esther Bernardo, (unknown), David Vivas, Piera Capranzano, Giovanni Malerba, Davide Capodanno, Paola Prandini, Alessandra Pasquali, Elisabetta Trabetti, Manel Sabaté, Pilar Jiménez‐Quevedo, José Luis Ferreiro, Masafumi Ueno, Theodore A. Bass, Pier Franco Pignatti, Antonio Fernández‐Ortíz, Carlos Macaya	45
17	SERUM COTININE LEVELS ARE ASSOCIATED WITH INCREASED CLOPIDOGREL-INDUCED ANTIPLATELET EFFECTS IN PATIENTS WITH DIABETES MELLITUS AND CORONARY ARTERY DISEASE 2011 ·Journal of the American College of Cardiology ·Masafumi Ueno, José Luis Ferreiro, Kodlipet Dharmashankar, Salvatore D. Tomasello, Antonio Tello‐Montoliu, Davide Capodanno, Murali Kodali, Naveen Seecheran, Andrew Darlington, Piera Capranzano, Bhaloo Desai, Ronald K. Charlton, Theodore A. Bass, Dominick J. Angiolillo	1
18	IMPACT OF CONCOMITANT AND STAGGERED PANTOPRAZOLE INTAKE ON PHARMACODYNAMIC EFFECTS INDUCED BY CLOPIDOGREL 2011 ·Journal of the American College of Cardiology ·José Luis Ferreiro, Masafumi Ueno, Salvatore D. Tomasello, Antonio Tello‐Montoliu, Davide Capodanno, Naveen Seecheran, (unknown), Murali Kodali, Andrew Darlington, Bhaloo Desai, Ronald K. Charlton, Theodore A. Bass, Dominick J. Angiolillo	0
19	Impact of Pentoxifylline on Platelet Function Profiles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel 2011 ·JACC: Cardiovascular Interventions ·Masafumi Ueno, José Luis Ferreiro, Salvatore D. Tomasello, Antonio Tello‐Montoliu, Davide Capodanno, Naveen Seecheran, Murali Kodali, Kodlipet Dharmashankar, Bhaloo Desai, Ronald K. Charlton, Theodore A. Bass, Dominick J. Angiolillo	15
20	Update on the clinical development of cangrelor 2010 ·Expert Review of Cardiovascular Therapy ·Masafumi Ueno, José Luis Ferreiro, Dominick J. Angiolillo	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact